[1]
Vynnychenko, O., Moskalenko, Y. and Moskalenko, R. 2025. Markers of inflammation as predictors of efficacy of trastuzumab therapy in HER2-positive metastatic breast cancer patients. Regulatory Mechanisms in Biosystems. 16, 1 (Jan. 2025), e25003. DOI:https://doi.org/10.15421/0225003.